Last week, one of NANEMIAR’s partners - Jenny van Asbeck (Mercurna) - had the opportunity to speak at the 4th RNA Leaders Congress in Basel, Switzerland. It was great to share Mercurna’s latest advancements in targeted mRNA therapy development and to network with fellow researchers, industry leaders, and investors, all passionate about the future of RNA technology.
RNA Leaders is the event focused on RNA medicines such as RNAi, antisense, non-linear RNAs, RNA editing and targeting RNA, as well as manufacturing development of mRNA therapies and vaccine. The event features 4 simultaneous tracks covering in-depth development strategies, trends and technologies across the entire long and small RNA spectrum and areas of focus.

Cathegory: Other related events